Clorox Company (The) (CLX) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.66
- Estimate
- $1.65
- Surprise
- +0.9%
- Score at report (before → after)
- 4.9 → 5.0/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Clorox Company (The) (CLX) beat the $1.65 estimate with adjusted EPS of $1.66 — a modest 0.9% upside surprise. TrendMatrix's engine moved from Hold (4.9/10) to Buy (Wait) at 5.0/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CLX Sell at 4.7/10.
3 of the last 4 quarters beat the estimate; this quarter's +0.9% surprise compares with a +3.3% four-quarter average. Next scheduled report: 2026-11-02.
What supports the rating
- Sector modifier (Consumer Defensive): +0.8
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Supplier: sole source or single-source suppliers
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $86.84
- Stop
- $82.54
The stock trades at 18.1× trailing but 14.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
CLX at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Household & Personal Products
- Market cap
- $10.50B
- P/E (fwd)
- 14.2
- P/E (ttm)
- 18.1
- 52-week range
- $79.12–$128.90
- Off 52-week high
- 32.6%
- RSI (14)
- 63
- Volume vs avg
- 0.98×
- Score today
- 4.7/10